Sirolimus and Antibody Replacement Fall Short of Proof in Rare Immune Syndrome Review
A systematic review of 79 records found no prospective trials of sirolimus or immunoglobulin replacement therapy in APDS, with evidence ...
Tag: mTOR inhibitor
POPULAR NEWS
-
Central obesity prevalence differs across Australian remoteness areas
-
XPAR-Net: cross-paradigm alignment and reconstruction network for high-fidelity lens-free on-chip microscopy
-
Iranian child-development providers report referral, funding and coordination barriers
-
Sirolimus and Antibody Replacement Fall Short of Proof in Rare Immune Syndrome Review